Nadine Stadtler

Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases.

J. Utikal, S. Haferkamp, D. Schadendorf, 2021, European journal of cancer.

Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis

C. Berking, D. Schadendorf, A. Gesierich, 2021, Frontiers in Oncology.

Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions

D. Schadendorf, P. Jansen, S. Ugurel, 2022, Cancers.

Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors

D. Schadendorf, P. Jansen, A. Bankfalvi, 2022, International journal of cancer.

Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants

D. Schadendorf, P. Jansen, E. Livingstone, 2022, Pigment cell & melanoma research.

Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system

D. Schadendorf, B. Schilling, R. Scolyer, 2016, Journal of Neuro-Oncology.

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions

J. Utikal, D. Schadendorf, B. Schilling, 2017, Nature Communications.